1. Home
  2. LOAN vs IXHL Comparison

LOAN vs IXHL Comparison

Compare LOAN & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.88

Market Cap

51.9M

Sector

Real Estate

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.43

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOAN
IXHL
Founded
1989
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
49.1M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
LOAN
IXHL
Price
$4.88
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.8K
24.9M
Earning Date
10-24-2025
11-14-2025
Dividend Yield
9.43%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$7,138,128.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$10.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.29
$0.08
52 Week High
$6.05
$2.25

Technical Indicators

Market Signals
Indicator
LOAN
IXHL
Relative Strength Index (RSI) 55.96 57.22
Support Level $4.64 $0.38
Resistance Level $4.94 $0.50
Average True Range (ATR) 0.12 0.04
MACD 0.05 0.01
Stochastic Oscillator 88.79 63.35

Price Performance

Historical Comparison
LOAN
IXHL

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: